The Food and Drug Administration authorized an updated formula for mRNA COVID-19 vaccines to adjust for the XBB1.5 variant this fall amid a surge in cases right after summer. With a long schedule of ...
A bivalent messenger RNA vaccine targeting both the ancestral and omicron BA.4–BA.5 sublineages of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Pfizer–BioNTech) was introduced in ...
With a budget of up to $20m, the collaboration will establish scalable, rapid manufacturing for recombinant-protein vaccines.
Researchers from Colgate University and Syracuse University found that politically conservative US adults living in liberal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results